Dr. Errol B. De Souza, Ph.D., serves as NonExecutive Director of Bionomics Limited since February 28, 2008. Dr. De Souza is in research and development concerning the central nervous system . He is the former President and Chief Executive Officer of US biotech companies Archemix Corporationrationration and Synaptic Pharmaceutical Corporationrationration. Dr. De Souza formerly held Senior Management positions at Aventis and its predecessor Hoechst Marion Roussel Pharmaceuticals, Inc. Most recently, he was Senior VicePresident and Site Head of US Drug Innovation and Approval, at Aventis, where he was responsible for the discovery and development of drug candidates through Phase IIa clinical trials for CN S and inflammatory disorders. Prior to Aventis, he was a cofounder and Chief Scientific Officer of Neurocrine Biosciences. Dr. De Souza serves on multiple editorial boards, National Institutes of Health Committees and is a director of several public and private companies.
The company has return on total asset (ROA) of (6.29) % which means that it has lost $6.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (13.47) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.09 M in total debt with debt to equity ratio (D/E) of 0.04 which may suggest the company is not taking enough advantage from borrowing. Bionomics Ltd has Current Ratio of 4.42 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Bionomics Limited, a biotechnology company, engages in the discovery and development of therapeutics for the treatment of cancer and disorders of the central nervous system in Australia and France. Bionomics Ltd [BNO] is traded on Australian Securities Exchange in Australia. It is located in Thebarton, SA and employs 11 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.29%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Frankfurt
Australian
